28 May Madison stem cell firm makes deal with medical school
A Madison company aiming to put itself at the center of the evolving field of regenerative medicine said Wednesday that it has licensed a key patent portfolio involving the differentiation of stem cells into heart cells.
Cellular Dynamics International negotiated an exclusive license to the technology from Mount Sinai School of Medicine in New York, the company said in a news release.
Read full article>>